SCHEMBL462237

SCHEMBL462237

C=CC[SiH2]N=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9382559 0.67
SCHEMBL861551 0.67
SCHEMBL4655401 0.67
SCHEMBL11668518 0.63
SCHEMBL9985379 0.63
SCHEMBL1235727 0.61
SCHEMBL27646870 0.61
SCHEMBL2692028 0.61
SCHEMBL20235926 0.61
SCHEMBL253042 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012032540-A1 PROCESS FOR PREPARATION OF FLUORINATED TRIAZOLE COMPOUND INDOCO REMEDIES LIMITED (IN) 2012-03-15 WO claimed
JP-5001000-A None JP disclosed
EP-3784659-A1 PROCESS FOR THE PREPARATION OF 1-(2-METHOXYMETHYL-3-METHYLPHENYL)4H-TETRAZOLIN-5-ONE BASF SE (DE) 2021-03-03 EP disclosed
US-8183269-B2 Process for the preparation of rufinamide CIPLA LIMITED (IN) 2012-05-22 US disclosed
WO-2012032540-A1 PROCESS FOR PREPARATION OF FLUORINATED TRIAZOLE COMPOUND INDOCO REMEDIES LIMITED (IN) 2012-03-15 WO disclosed
US-20110207938-A1 Process for the Preparation of Rufinamide CIPLA LIMITED (IN) 2011-08-25 US disclosed
EP-2334653-A1 PROCESS FOR THE PREPARATION OF RUFINAMIDE Cilpa Limited (IN) 2011-06-22 EP disclosed
US-20100105904-A1 UREA TYPE CINNAMIDE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-04-29 US disclosed
WO-2010043849-A1 PROCESS FOR THE PREPARATION OF RUFINAMIDE CIPLA LIMITED (IN) 2010-04-22 WO disclosed
EP-2019093-A1 UREA TYPE CINNAMIDE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2009-01-28 EP disclosed
EP-1026167-B1 TRICYCLIC TRIAZOLOBENZAZEPINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND ANTIALLERGIC AGENTS MEIJI SEIKA KAISHA (JP) 2003-03-05 EP disclosed
US-20020137739-A1 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents MEIJI SEIKA PHARMA CO., LTD. (JP) 2002-09-26 US disclosed
US-6372735-B1 ANTIHISTAMINES MEIJI SEIKA KAISHA, LTD. (JP) 2002-04-16 US disclosed
EP-1026167-A1 TRICYCLIC TRIAZOLOBENZAZEPINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND ANTIALLERGIC MEIJI SEIKA KAISHA LTD. (JP) 2000-08-09 EP disclosed
EP-0744402-B1 POTASSIUM SALT OF BIPHENYLMETHANE DERIVATIVE AND MEDICINE CONTAINING THE SAME WAKUNAGA SEIYAKU KK (JP) 1998-07-29 EP disclosed
US-5654322-A HYPOTENSIVE AGENTS, CEREBRAL APOPLEXY WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1997-08-05 US disclosed
EP-0744402-A1 POTASSIUM SALT OF BIPHENYLMETHANE DERIVATIVE AND MEDICINE CONTAINING THE SAME WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1996-11-27 EP disclosed
JP-H051000-A CYCLOHEXYL BUTYRIC ACID DERIVATIVE AND ITS PRODUCTION TAKASAGO INTERNATL CORP 1993-01-08 JP disclosed
US-4310527-A DISORDERS OF CAROIAC RHYTHM AND CORONARY HEART DISEASES AND HYDPERTENSION CIBA-GEIGY CORPORATION (US) 1982-01-12 US disclosed
US-4140789-A ADRENERGIC BLOCKING AGENTS, CARDIOTONIC, ANTIARRHYTHMIA, HYPOTENSIVE CIBA-GEIGY CORPORATION (US) 1979-02-20 US disclosed